← Back to all trials
Recruiting
NCT07788534
This Study Aims to Compare Asthma Control in Children Monitored With FeNO Against a Historical Cohort Without FeNO. Secondary Objectives Include Evaluating Associations Between FeNO Levels, ACT/C-ACT Scores, Eosinophil Counts, FEV1%, ICS Adherence, and Exacerbation Frequency.
Conditions: Asthma Childhood
Sex: All
Ages: 6 Years – 14 Years
Healthy volunteers: No
Phase: NA
Enrollment: 80
Sponsor: King Faisal Specialist Hospital & Research Center
Location: King Faisal Sepiclaized Hospital and Research Center Jeddah Mecca Region
Summary
This study aims to evaluate whether incorporating FeNO monitoring into routine pediatric asthma care improves clinical outcomes relative to a historical cohort managed without FeNO
Eligibility Criteria
Inclusion Criteria:
* Children aged 6 to 14 years with a physician-diagnosed asthma.
* Minimum of three months' follow-up at the pediatric respiratory clinic.
* Availability of Asthma Control Test (ACT/C-ACT) scores and clinical data
Exclusion Criteria:
* Presence of other chronic pulmonary diseases (e.g., cystic fibrosis).
* Recent respiratory infections within four weeks prior to enrollment.
* Current treatment with biologic agents affecting asthma inflammation.
Source: ClinicalTrials.gov (NCT07788534). StuddyBuddy aggregates publicly available trial information.
